![Bjorn Hofman](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Bjorn Hofman
Président chez
ILC Dover LP
Profil
Bjorn Hofman occupe le poste de directeur de l'exploitation et vice-président exécutif chez Avantor, Inc. Auparavant, il a occupé le poste de directeur commercial de la région EMEA chez Celanese Corp. et celui de premier vice-président des technologies avancées chez Merck KGaA. M. Hofman a obtenu un diplôme d'études supérieures de l'université de technologie de Delft.
Postes actifs de Bjorn Hofman
| Sociétés | Poste | Début |
|---|---|---|
New Mountain Capital LLC
 New Mountain Capital LLC Investment ManagersFinance New Mountain Capital invests in middle market companies located in the United States with an enterprise value of USD 100 - 1000 million. The firm focuses on a broad range of sectors and industries. It provides financing for add-on acquisitions, buyout and growth transactions with a transaction size ranging USD 100 - 500 million. It also acquires majority control and minority equity positions. | Consultant / Advisor | 01/01/2020 |
ILC Dover LP
 ILC Dover LP Pharmaceuticals: MajorHealth Technology Designs and manufactures biopharmaceutical, pharmaceutical and medical devices | Président | - |
Anciens postes connus de Bjorn Hofman
| Sociétés | Poste | Fin |
|---|---|---|
| AVANTOR, INC. | Directeur des opérations | 01/01/2020 |
| MERCK KGAA | Corporate Officer/Principal | 01/01/2014 |
| CELANESE CORPORATION | Corporate Officer/Principal | 01/01/2013 |
Formation de Bjorn Hofman
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
77
Relations au 1er degré
6
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 6 |
|---|---|
Merck KGaA
 Merck KGaA Pharmaceuticals: MajorHealth Technology Engages in the manufacturing of pharmaceutical and chemical products | Health Technology |
Celanese Corp.
 Celanese Corp. Chemicals: SpecialtyProcess Industries Produces acetyl products and engineered polymers | Process Industries |
ILC Dover LP
ILC Dover LP Pharmaceuticals: MajorHealth Technology Designs and manufactures biopharmaceutical, pharmaceutical and medical devices | Health Technology |
New Mountain Capital LLC
New Mountain Capital LLC Investment ManagersFinance New Mountain Capital invests in middle market companies located in the United States with an enterprise value of USD 100 - 1000 million. The firm focuses on a broad range of sectors and industries. It provides financing for add-on acquisitions, buyout and growth transactions with a transaction size ranging USD 100 - 500 million. It also acquires majority control and minority equity positions. | Finance |
Delft University of Technology
 Delft University of Technology Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Avantor, Inc.
 Avantor, Inc. Medical SpecialtiesHealth Technology Manufactures and supplies laboratory equipment and bioscience products | Health Technology |
